Literature DB >> 23542594

The comparison of neuroprotective effects of intrathecal dexmedetomidine and metilprednisolone in spinal cord injury.

Feyzi Celik1, Cüneyt Göçmez, Kağan Kamaşak, Adnan Tufek, Abdulmenap Guzel, Orhan Tokgoz, Uğur Fırat, Osman Evliyaoğlu.   

Abstract

BACKGROUND: The purpose of this study is the investigation of the effects of intrathecally injected dexmedetomidine and methylprednisolone and their dominancy over one another in rats with generated Spinal Cord Injury (SCI).
METHODS: 40, female, adult Wistar Albino rats weighing 220-260 g were included in the study. The rats were fixed with Intrathecal catheter (IT) and divided into four groups. All subjects were applied T7-10 laminectomy after catheter. Group S (n:10) was injected with IT 10 μL isotonic saline; Group C (n:10) with IT 10 μL isotonic saline after SCI; Group D (n:10) with IT one doze 10 μL of dexmedetomidine after SCI; Group M (n:10) IT one dose 10 μL of methylprednisolone. The subjects were sacrificed 72 h after this operation. The damaged area was removed biochemically and histopathologically examined.
RESULTS: Antioxidant and inflammatory parameters searched for in all damages tissue were statistically different in all groups from group S. They were different in group M and group D than group C (p < 0.001). After the comparison of group D and group M, PON and IL6 values were higher in group D (p = 0.003, p = 0.035) while the other two biochemical parameters were similar in both groups (Table 1). After histopathologic trials, edemas, bleeding and necrosis were found less in group S while at the most in group C (p < 0.001). In group M and group D, however, they were higher than group S and lower than group C (p < 0.001). After the comparison of group D and group M, while there was no difference in terms of edema necrosis, the amount of bleeding was lower in group D (p < 0.001) (Table 2).
CONCLUSIONS: It has been discovered that intrathecal use of dexmedetomidine caused neuroprotective effects similar to methylprednisolone.
Copyright © 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542594     DOI: 10.1016/j.ijsu.2013.03.008

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  10 in total

1.  The Pathway of Let-7a-1/2-3p and HMGB1 Mediated Dexmedetomidine Inhibiting Microglia Activation in Spinal Cord Ischemia-Reperfusion Injury Mice.

Authors:  Ming Nuo; Qing-Tao Meng; Zhong-Yuan Xia
Journal:  J Mol Neurosci       Date:  2019-06-12       Impact factor: 3.444

2.  Efficacy of dexmedetomidine as an adjuvant in paravertebral block in breast cancer surgery.

Authors:  Medha Mohta; Bhumika Kalra; Ashok K Sethi; Navneet Kaur
Journal:  J Anesth       Date:  2015-12-22       Impact factor: 2.078

3.  Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure.

Authors:  Manuel F Giraldo-Velásquez; Iván N Pérez-Osorio; Alejandro Espinosa-Cerón; Brandon M Bárcena; Arturo Calderón-Gallegos; Gladis Fragoso; Mónica Torres-Ramos; Nayeli Páez-Martínez; Edda Sciutto
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

4.  Comparison of intrathecal dexmedetomidine with buprenorphine as adjuvant to bupivacaine in spinal asnaesthesia.

Authors:  Mahima Gupta; S Shailaja; K Sudhir Hegde
Journal:  J Clin Diagn Res       Date:  2014-02-03

5.  Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury.

Authors:  Jiandong Gao; Zhihua Sun; Zhaoyang Xiao; Qihang Du; Xinhuan Niu; Gongming Wang; Yu-Wen Chang; Yongtao Sun; Wei Sun; Amity Lin; Jacqueline C Bresnahan; Mervyn Maze; Michael S Beattie; Jonathan Z Pan
Journal:  Br J Anaesth       Date:  2019-10-14       Impact factor: 9.166

6.  Neuraxial dexmedetomidine: wonder drug or simply harmful.

Authors:  Sohan Lal Solanki; Vipin Kumar Goyal
Journal:  Anesth Pain Med       Date:  2015-03-30

Review 7.  The role of pharmacotherapy in modifying the neurological status of patients with spinal and spinal cord injuries.

Authors:  Renato Carlos do Vale Ramos; Nuno Alegrete
Journal:  Rev Bras Ortop       Date:  2015-10-01

8.  Subarachnoid and epidural dexmedetomidine for the prevention of post-anesthetic shivering: a meta-analysis and systematic review.

Authors:  Yi-Zheng Li; Yi Jiang; Han Lin; Xue-Ping Yang
Journal:  Drug Des Devel Ther       Date:  2019-11-01       Impact factor: 4.162

9.  Thoracic Paravertebral Nerve Block with Ropivacaine and Adjuvant Dexmedetomidine Produced Longer Analgesia in Patients Undergoing Video-Assisted Thoracoscopic Lobectomy: A Randomized Trial.

Authors:  Jun Zha; Shiliang Ji; Chen Wang; Zhe Yang; Shigang Qiao; Jianzhng An
Journal:  J Healthc Eng       Date:  2021-09-08       Impact factor: 2.682

10.  Therapeutic effects of thymoquinone in a model of neuropathic pain.

Authors:  Feyzi Celik; Cüneyt Göçmez; Haktan Karaman; Kağan Kamaşak; Ibrahim Kaplan; Eşref Akıl; Adnan Tufek; Abdulmenap Guzel; Ertuğrul Uzar
Journal:  Curr Ther Res Clin Exp       Date:  2014-01-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.